MILRINONE LACTATE IN DEXTROSE 5% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Milrinone Lactate In Dextrose 5%, and when can generic versions of Milrinone Lactate In Dextrose 5% launch?
Milrinone Lactate In Dextrose 5% is a drug marketed by Eugia Pharma, Woodward, B Braun, Baxter Hlthcare, Gland Pharma Ltd, Hikma, Hospira, and West-ward Pharms Int. and is included in nine NDAs.
The generic ingredient in MILRINONE LACTATE IN DEXTROSE 5% is milrinone lactate. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Milrinone Lactate In Dextrose 5%
A generic version of MILRINONE LACTATE IN DEXTROSE 5% was approved as milrinone lactate by FRESENIUS KABI USA on May 28th, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MILRINONE LACTATE IN DEXTROSE 5%?
- What are the global sales for MILRINONE LACTATE IN DEXTROSE 5%?
- What is Average Wholesale Price for MILRINONE LACTATE IN DEXTROSE 5%?
Summary for MILRINONE LACTATE IN DEXTROSE 5%
US Patents: | 0 |
Applicants: | 8 |
NDAs: | 9 |
Finished Product Suppliers / Packagers: | 5 |
Clinical Trials: | 5 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MILRINONE LACTATE IN DEXTROSE 5% at DailyMed |
![MILRINONE LACTATE IN DEXTROSE 5% drug patent expirations Drug patent expirations by year for MILRINONE LACTATE IN DEXTROSE 5%](/p/graph/s/t/MILRINONE_LACTATE_IN_DEXTROSE_5%-patent-expirations.png)
Recent Clinical Trials for MILRINONE LACTATE IN DEXTROSE 5%
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Shanghai Children's Medical Center | Phase 3 |
Ottawa Heart Institute Research Corporation | Phase 4 |
Bedford Pharmaceuticals | N/A |
Pharmacology for MILRINONE LACTATE IN DEXTROSE 5%
Drug Class | Phosphodiesterase 3 Inhibitor |
Mechanism of Action | Phosphodiesterase 3 Inhibitors |